Trusts required to show they are providing NICE approved treatmentsBMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e5819 (Published 28 August 2012) Cite this as: BMJ 2012;345:e5819
- Matthew Limb
The government is to insist that NHS organisations that restrict treatments approved by the National Institute for Health and Clinical Excellence (NICE) face public scrutiny.
From this autumn, patients will be able to see whether approved drugs and treatments are being provided in their areas by hospitals and commissioning authorities.
“If they are not, they [NHS organisations] will now be responsible for explaining why not,” health minister Paul Burstow said.
He said the new regime would be a “catalyst for change” that would eradicate variation and uphold standards for all patients. “Being transparent with data like this is the hallmark of a 21st century NHS,” he said.
Under the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial